Mark A. Eckardt

1.1k total citations
31 papers, 511 citations indexed

About

Mark A. Eckardt is a scholar working on Pulmonary and Respiratory Medicine, Biomedical Engineering and Oncology. According to data from OpenAlex, Mark A. Eckardt has authored 31 papers receiving a total of 511 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 11 papers in Biomedical Engineering and 10 papers in Oncology. Recurrent topics in Mark A. Eckardt's work include Sarcoma Diagnosis and Treatment (13 papers), Cancer Research and Treatments (9 papers) and Virus-based gene therapy research (8 papers). Mark A. Eckardt is often cited by papers focused on Sarcoma Diagnosis and Treatment (13 papers), Cancer Research and Treatments (9 papers) and Virus-based gene therapy research (8 papers). Mark A. Eckardt collaborates with scholars based in United States, Japan and Germany. Mark A. Eckardt's co-authors include Fritz C. Eilber, Arun S. Singh, Scott D. Nelson, Jason T. Hamamoto, Jeffrey C. Wang, Remi M. Ajiboye, Nicholas M. Bernthal, Sarah Dry, Jeffrey J. Eċkardt and Kei Kawaguchi and has published in prestigious journals such as Journal of Clinical Oncology, Biochemical and Biophysical Research Communications and The Journal of Urology.

In The Last Decade

Mark A. Eckardt

29 papers receiving 509 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark A. Eckardt United States	13	200	156	155	114	89	31	511
Elizabeth Shurell United States	8	342 1.7×	228 1.5×	76 0.5×	65 0.6×	86 1.0×	11	557
Toru Wakamatsu Japan	14	235 1.2×	206 1.3×	17 0.1×	47 0.4×	90 1.0×	58	541
M. Morell Spain	13	73 0.4×	231 1.5×	26 0.2×	43 0.4×	105 1.2×	25	569
Nobuyuki Kusaka Japan	14	134 0.7×	195 1.3×	53 0.3×	17 0.1×	55 0.6×	27	564
David F. Dexter Canada	13	108 0.5×	199 1.3×	39 0.3×	19 0.2×	99 1.1×	20	455
Trupti Trivedi India	13	108 0.5×	417 2.7×	22 0.1×	31 0.3×	76 0.9×	34	656
Masato Igarashi Japan	14	37 0.2×	130 0.8×	18 0.1×	67 0.6×	89 1.0×	38	587
Rakesh Donthineni-Rao United States	7	227 1.1×	86 0.6×	25 0.2×	13 0.1×	74 0.8×	16	395
Ruisen Zhu China	12	76 0.4×	137 0.9×	22 0.1×	17 0.1×	150 1.7×	26	472
Aleksandar Francki United States	11	32 0.2×	83 0.5×	53 0.3×	17 0.1×	87 1.0×	11	573

Countries citing papers authored by Mark A. Eckardt

Since Specialization

Citations

This map shows the geographic impact of Mark A. Eckardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Eckardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Eckardt more than expected).

Fields of papers citing papers by Mark A. Eckardt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Eckardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Eckardt. The network helps show where Mark A. Eckardt may publish in the future.

Co-authorship network of co-authors of Mark A. Eckardt

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Eckardt. A scholar is included among the top collaborators of Mark A. Eckardt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Eckardt. Mark A. Eckardt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Eckardt, Mark A., Amy R. Copeland, Tyler R. McCaw, et al.. (2025). Dedicated review of sarcoma pathology is necessary for corroborative diagnosis in nearly one half of referred patients. Surgery. 188. 109610–109610.

Eckardt, Mark A., Serena Lofftus, Tyler R. McCaw, et al.. (2022). Lifelong Imaging Surveillance is Indicated for Patients with Primary Retroperitoneal Liposarcoma. Annals of Surgical Oncology. 30(5). 3097–3103. 6 indexed citations

Nelson, Scott D., et al.. (2021). Aggressive osteoblastoma with a secondary aneurysmal bone cyst treated with denosumab. Rare Tumors. 13. 734626902–734626902. 8 indexed citations

Crompton, Joseph G., Wesley R. Armstrong, Mark A. Eckardt, et al.. (2021). ¹⁸F-FLT PET/CT as a prognostic imaging biomarker of disease specific survival in patients with primary soft tissue sarcoma. Journal of Nuclear Medicine. 63(5). jnumed.121.262502–jnumed.121.262502. 2 indexed citations

Adashek, Jacob J., Mark A. Eckardt, Bartosz Chmielowski, et al.. (2021). Translating Knowledge About the Immune Microenvironment of Gastrointestinal Stromal Tumors into Effective Clinical Strategies. Current Treatment Options in Oncology. 22(1). 9–9. 4 indexed citations

Eckardt, Mark A., Arun S. Singh, Bartosz Chmielowski, et al.. (2019). Pathologic discordance in sarcomas: Prospective comparison of external and sarcoma center pathologic diagnosis.. Journal of Clinical Oncology. 37(15_suppl). 11020–11020. 3 indexed citations

Igarashi, Kentaro, Kei Kawaguchi, Tasuku Kiyuna, et al.. (2018). Tumor-targeting Salmonella typhimurium A1-R is a highly effective general therapeutic for undifferentiated soft tissue sarcoma patient-derived orthotopic xenograft nude-mouse models. Biochemical and Biophysical Research Communications. 497(4). 1055–1061. 26 indexed citations

Kiyuna, Tasuku, Yasunori Tome, Takashi Murakami, et al.. (2018). Tumor‐targeting Salmonella typhimurium A1‐R arrests a doxorubicin‐resistant PDGFRA‐amplified patient‐derived orthotopic xenograft mouse model of pleomorphic liposarcoma. Journal of Cellular Biochemistry. 119(9). 7827–7833. 8 indexed citations

Russell, Tara A., Mark A. Eckardt, Takashi Murakami, et al.. (2017). Clinical Factors That Affect the Establishment of Soft Tissue Sarcoma Patient-Derived Orthotopic Xenografts: A University of California, Los Angeles, Sarcoma Program Prospective Clinical Trial. JCO Precision Oncology. 2017(1). 1–13. 7 indexed citations

10.

Igarashi, Kentaro, Kei Kawaguchi, Tasuku Kiyuna, et al.. (2017). Temozolomide combined with irinotecan regresses a cisplatinum-resistant relapsed osteosarcoma in a patient-derived orthotopic xenograft (PDOX) precision-oncology mouse model. Oncotarget. 9(8). 7774–7781. 21 indexed citations

11.

Ajiboye, Remi M., et al.. (2016). Outcomes of Demineralized Bone Matrix Enriched with Concentrated Bone Marrow Aspirate in Lumbar Fusion. The International Journal of Spine Surgery. 10. 35–35. 18 indexed citations

12.

Kiyuna, Tasuku, Takashi Murakami, Yasunori Tome, et al.. (2016). Labeling the Stroma of a Patient-Derived Orthotopic Xenograft (PDOX) Mouse Model of Undifferentiated Pleomorphic Soft-Tissue Sarcoma With Red Fluorescent Protein for Rapid Non-Invasive Imaging for Drug Screening. Journal of Cellular Biochemistry. 118(2). 361–365. 27 indexed citations

13.

Ajiboye, Remi M., Jason T. Hamamoto, Mark A. Eckardt, & Jeffrey C. Wang. (2015). Clinical and radiographic outcomes of concentrated bone marrow aspirate with allograft and demineralized bone matrix for posterolateral and interbody lumbar fusion in elderly patients. European Spine Journal. 24(11). 2567–2572. 39 indexed citations

14.

Mitton, Bryan, Leanne L. Seeger, Mark A. Eckardt, et al.. (2013). Image-guided Percutaneous Core Needle Biopsy of Musculoskeletal Tumors in Children. Journal of Pediatric Hematology/Oncology. 36(5). 337–341. 22 indexed citations

15.

Kalous, Ondrej, Dylan Conklin, Amrita Desai, et al.. (2013). AMG 900, pan-Aurora kinase inhibitor, preferentially inhibits the proliferation of breast cancer cell lines with dysfunctional p53. Breast Cancer Research and Treatment. 141(3). 397–408. 22 indexed citations

16.

Desai, Amrita, Erika von Euw, Dylan Conklin, et al.. (2013). PD-0332991, a potent and selective inhibitor of cyclin-dependent kinase 4/6, demonstrates inhibition of proliferation in renal cell carcinoma at nanomolar concentrations and molecular markers predict for sensitivity.. PubMed. 33(8). 2997–3004. 88 indexed citations

17.

Eckardt, Mark A., et al.. (2013). A Child With Gemcitabine-induced Severe Radiation Recall Myositis Resulting in a Compartment Syndrome. Journal of Pediatric Hematology/Oncology. 35(2). 156–161. 15 indexed citations

18.

Kremen, Thomas J., Nicholas M. Bernthal, Mark A. Eckardt, & Jeffrey J. Eċkardt. (2011). Giant Cell Tumor of Bone: Are We Stratifying Results Appropriately?. Clinical Orthopaedics and Related Research. 470(3). 677–683. 35 indexed citations

19.

Kampfenkel, Tobias, Iris Tischoff, Mark A. Eckardt, et al.. (2011). Chemotherapieassoziierte Leberveränderungen bei Patienten mit kolorektalem Karzinom und operativer Entfernung von Lebermetastasen: Evaluierung eines histopathologischen Scores und Erhebung präoperativer Risikofaktoren. Zeitschrift für Gastroenterologie. 49(10). 1407–1411. 2 indexed citations

20.

Eckardt, Mark A., Vivian Y. Chang, Nagesh Rao, & Noah Federman. (2011). Coexistence of Translocation(1,19) and the Philadelphia Chromosome in a Child's First Presentation of Chronic Myeloid Leukemia in Blast Crisis Treated with Dasatinib. Pediatric Hematology and Oncology. 28(8). 669–675.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact